You are here:   Videos
Register   |  Login

Get Adobe Flash player Install latest flash player if this video gallery doesn't work.
Bosutinib Versus Imatinib (CML) Follow-up Study — interview with Carlo Gambacorti-Passerini, MD, at ASH 2011
At the American Society of Hematology (ASH) 2011, Carlo Gambacorti-Passerini, MD, Professor of Internal Medicine at the University of Milano Bicocca, and Director of the Clinical Research Unit, San Gerardo Hospital in Monza, Italy, discusses bosutinib versus imatinib in newly diagnosed chronic phase chronic myeloid leukemia — BELA Trial: 24-month follow-up

Accompanying this interview are two downloadable copies of the abstract.
Recent Video
| 
Most Viewed
Tumor Type : Search :